ArticleClinicoEconomics and outcomes research : CEOR2017

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab.

Tyler Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.